Home » Values clash » Wild & New Stuff » #WCE2014 – The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients – Abstract | Prostate Cancer | UroToday

#WCE2014 – The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients – Abstract | Prostate Cancer | UroToday

Abiraterone Acetate and Docetaxel, mcrpc, zytiga, advanced prostate cancer treatments, prostate cancer, GU oncology news, urology news, asco (#WCE2014 – The use of exome genotyping to predict pathological Gleason score upgrade after radical…

Source: urotoday.com

See on Scoop.itProstate Cancer: Psycho-Social Aspects to Disease Pathway Management

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: